Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements
| Concept |
As at 2019-03-31 |
2018-04-01 to 2019-03-31 |
|---|---|---|
| Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements | ||
| Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements | ||
| Disclosure of scope of consolidation | ||
| Number of consolidated subsidiaries and names of major consolidated subsidiaries | — |
(1）連結子会社の数及び名称 1社 栄研生物科技(中国)有限公司 |
| Number of consolidated subsidiaries |
1
xbrli:pure
|
— |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation | — |
(2）非連結子会社の数及び名称 該当事項はありません。 |
| Disclosure about application of equity method | ||
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method | — |
２．持分法の適用に関する事項 該当事項はありません。 |
| Disclosure about fiscal years, etc. of consolidated subsidiaries | — |
３．連結子会社の事業年度等に関する事項 連結子会社である栄研生物科技(中国)有限公司の決算日は12月31日であります。 連結財務諸表の作成にあたっては、正規の決算に準ずる合理的な手続きによる決算（仮決算）を実施する方法によって作成しております。 |